<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35288304</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>11</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1095-953X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>168</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>15</Day>
            </PubDate>
          </JournalIssue>
          <Title>Neurobiology of disease</Title>
          <ISOAbbreviation>Neurobiol Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>P2X7-dependent constitutive Interleukin-1β release from pyramidal neurons of the normal mouse hippocampus: Evidence for a role in maintenance of the innate seizure threshold.</ArticleTitle>
        <Pagination>
          <StartPage>105689</StartPage>
          <MedlinePgn>105689</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nbd.2022.105689</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0969-9961(22)00080-8</ELocationID>
        <Abstract>
          <AbstractText>Disruption of Interleukin-1β (IL-1β) signaling sensitized mice to convulsant stimuli, suggesting that this quintessential cytokine of the innate immune system contributes to maintenance of the innate seizure threshold (ST). However, much remains unknown about where and how IL-1β secretion occurs in the normal brain. This study examined the possibility that neurons of the hippocampus are key sources of constitutive IL-1β secretion and that the release from these cells is dependent on the purinoceptor, P2X7. It was posited that treatment with the P2X7 antagonist, JNJ-47965567 (JNJ), would cause IL-1β to accumulate in cells that produce it, and consequently, lower the ST. No IL-1β immunoreactivity was detected in any region of the hippocampal formation of mice treated with the JNJ vehicle, Sulfobutylether-β-cyclodextrin. In contrast, prominent immunoreactivity was discovered in the pyramidal neurons of the CA3 region 60 min after treatment with the P2X7 antagonist. Lower levels were found in CA1 neurons, and no immunoreactivity was detected in granule cells of the dentate gyrus. JNJ also increased IL-1β immunoreactivity in the cell bodies of hippocampal neurons in culture. Interestingly, JNJ potentiated bicuculline-induced Fos and COX-2 mRNA expression in the cultures and this was blocked by an NMDA receptor antagonist. Moreover, pentylenetetrazole-induced seizure severity and incidence of convulsions were increased in mice treated with JNJ and this resembled that observed with IL-1 signaling-deficient mice. Overall, the results from this study support the notion that constitutive P2X7-dependent IL-1β release from hippocampal pyramidal neurons contributes to maintenance of the ST in the normal brain, perhaps by modulating neuronal excitability. These findings may have implications for epilepsy, a brain disorder in which the ST is compromised.</AbstractText>
          <CopyrightInformation>Copyright © 2022. Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dutta</LastName>
            <ForeName>Spandita S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Program in Neuroscience, Syracuse University, Syracuse, NY 13244, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andonova</LastName>
            <ForeName>Antoaneta A</ForeName>
            <Initials>AA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Program in Neuroscience, Syracuse University, Syracuse, NY 13244, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wöellert</LastName>
            <ForeName>Torsten</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology and Visual Sciences, Center for Vision Research, SUNY Upstate Medical University, Syracuse, NY 13210, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hewett</LastName>
            <ForeName>Sandra J</ForeName>
            <Initials>SJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Program in Neuroscience, Syracuse University, Syracuse, NY 13244, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hewett</LastName>
            <ForeName>James A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biology and Program in Neuroscience, Syracuse University, Syracuse, NY 13244, United States of America. Electronic address: jhewett@syr.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS051445</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Neurobiol Dis</MedlineTA>
        <NlmUniqueID>9500169</NlmUniqueID>
        <ISSNLinking>0969-9961</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D058486">Receptors, Purinergic P2X7</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017966" MajorTopicYN="Y">Pyramidal Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058486" MajorTopicYN="N">Receptors, Purinergic P2X7</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012640" MajorTopicYN="Y">Seizures</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">CA3</Keyword>
        <Keyword MajorTopicYN="Y">Hippocampus</Keyword>
        <Keyword MajorTopicYN="Y">Interleukin-1β</Keyword>
        <Keyword MajorTopicYN="Y">P2X7</Keyword>
        <Keyword MajorTopicYN="Y">Pentylenetetrazole</Keyword>
        <Keyword MajorTopicYN="Y">Seizure threshold</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>5</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35288304</ArticleId>
        <ArticleId IdType="mid">NIHMS1791544</ArticleId>
        <ArticleId IdType="pmc">PMC9067394</ArticleId>
        <ArticleId IdType="doi">10.1016/j.nbd.2022.105689</ArticleId>
        <ArticleId IdType="pii">S0969-9961(22)00080-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Afonina IS, Muller C, Martin SJ, and Beyaert R
2015. Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. Immunity. 42:991–1004. doi: 10.1016/j.immuni.2015.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2015.06.003</ArticleId>
            <ArticleId IdType="pubmed">26084020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, and Tschopp J
2004. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 20:319–325. doi: 10.1016/s1074-7613(04)00046-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1074-7613(04)00046-9</ArticleId>
            <ArticleId IdType="pubmed">15030775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andre V, Pineau N, Motte JE, Marescaux C, and Nehlig A
1998. Mapping of neuronal networks underlying generalized seizures induced by increasing doses of pentylenetetrazol in the immature and adult rat: a c-Fos immunohistochemical study. EurJ Neurosci. 10:2094–2106. doi: 10.1046/j.1460-9568.1998.00223.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1460-9568.1998.00223.x</ArticleId>
            <ArticleId IdType="pubmed">9753096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anelli T, and Sitia R
2008. Protein quality control in the early secretory pathway. EMBO J. 27:315–327. doi: 10.1038/sj.emboj.7601974.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.emboj.7601974</ArticleId>
            <ArticleId IdType="pmc">PMC2234347</ArticleId>
            <ArticleId IdType="pubmed">18216874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armstrong JN, Brust TB, Lewis RG, and MacVicar BA
2002. Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase. J Neurosci. 22:5938–5945. doi: 10.1523/JNEUROSCI.22-14-05938.2002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.22-14-05938.2002</ArticleId>
            <ArticleId IdType="pmc">PMC6757920</ArticleId>
            <ArticleId IdType="pubmed">12122056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ban E, Milon G, Prudhomme N, Fillion G, and Haour F
1991. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience. 43:21–30. doi: 10.1016/0306-4522(91)90412-h.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0306-4522(91)90412-h</ArticleId>
            <ArticleId IdType="pubmed">1833666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bandtlow CE, Meyer M, Lindholm D, Spranger M, Heumann R, and Thoenen H
1990. Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNAin the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol. 111:1701–1711. doi: 10.1083/jcb.111.4.1701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.111.4.1701</ArticleId>
            <ArticleId IdType="pmc">PMC2116238</ArticleId>
            <ArticleId IdType="pubmed">2211833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beaudoin GM 3rd, Lee SH, Singh D, Yuan Y, Ng YG, Reichardt LF, and Arikkath J
2012. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat Protoc. 7:1741–1754. doi: 10.1038/nprot.2012.099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nprot.2012.099</ArticleId>
            <ArticleId IdType="pubmed">22936216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhattacharya A, Wang Q, Ao H, Shoblock JR, Lord B, Aluisio L, Fraser I, Nepomuceno D, Neff RA, Welty N, Lovenberg TW, Bonaventure P, Wickenden AD, and Letavic MA
2013. Pharmacological characterization of a novel centrally permeableP2X7 receptor antagonist: JNJ-47965567. Br J Pharmacol. 170:624–640. doi: 10.1111/bph.12314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bph.12314</ArticleId>
            <ArticleId IdType="pmc">PMC3792000</ArticleId>
            <ArticleId IdType="pubmed">23889535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breder CD, Dinarello CA, and Saper CB
1988. Interleukin-1 immunoreactive innervation ofthe human hypothalamus. Science. 240:321–324. doi: 10.1126/science.3258444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.3258444</ArticleId>
            <ArticleId IdType="pubmed">3258444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brevard ME, Kulkarni P, King JA, and Ferris CF
2006. Imaging the neural substrates involved in the genesis of pentylenetetrazol-induced seizures. Epilepsia
47:745–754. doi: 10.1111/j.1528-1167.2006.00502.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1528-1167.2006.00502.x</ArticleId>
            <ArticleId IdType="pubmed">16650141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Claycomb RJ, Hewett SJ, and Hewett JA
2011. Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition. Epilepsia
52:273–283. doi: 10.1111/j.1528-1167.2010.02889.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1528-1167.2010.02889.x</ArticleId>
            <ArticleId IdType="pmc">PMC4445939</ArticleId>
            <ArticleId IdType="pubmed">21219314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Claycomb RJ, Hewett SJ, and Hewett JA
2012. Neuromodulatory role of endogenous interleukin-1beta in acute seizures: possible contribution of cyclooxygenase-2. NeurobiolDis. 45:234–242. doi: 10.1016/j.nbd.2011.08.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2011.08.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cole AJ, Saffen DW, Baraban JM, and Worley PF
1989. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature
340:474–476. doi: 10.1038/340474a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/340474a0</ArticleId>
            <ArticleId IdType="pubmed">2547165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conos SA, Lawlor KE, Vaux DL, Vince JE, and Lindqvist LM
2016. Cell death is not essential for caspase-1-mediated interleukin-1beta activation and secretion. Cell Death Differ. 23:1827–1838. doi: 10.1038/cdd.2016.69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2016.69</ArticleId>
            <ArticleId IdType="pmc">PMC5071572</ArticleId>
            <ArticleId IdType="pubmed">27419363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coulter DA, and Carlson GC
2007. Functional regulation of the dentate gyrus by GABA-mediated inhibition. Prog Brain Res. 163:235–243. doi: 10.1016/S0079-6123(07)63014-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0079-6123(07)63014-3</ArticleId>
            <ArticleId IdType="pubmed">17765722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham ET Jr., Wada E, Carter DB, Tracey DE, Battey JF, and De Souza EB
1992. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci. 12:1101–1114. doi: 10.1523/JNEUROSCI.12-03-01101.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.12-03-01101.1992</ArticleId>
            <ArticleId IdType="pmc">PMC6576039</ArticleId>
            <ArticleId IdType="pubmed">1532025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deyerle KL, Sims JE, Dower SK, and Bothwell MA
1992. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol. 149:1657–1665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1387148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diana A, Van Dam AM, Winblad B, and Schultzberg M
1999. Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus. Neuroscience
89:137–147. doi: 10.1016/s0306-4522(98)00274-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0306-4522(98)00274-7</ArticleId>
            <ArticleId IdType="pubmed">10051223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinarello CA
2009. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 27:519–550. doi: 10.1146/annurev.immunol.021908.132612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.immunol.021908.132612</ArticleId>
            <ArticleId IdType="pubmed">19302047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dubyak GR
2012. P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 14:1697–1706. doi: 10.1111/cmi.12001. Epub 2012 Aug 24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12001</ArticleId>
            <ArticleId IdType="pmc">PMC3473166</ArticleId>
            <ArticleId IdType="pubmed">22882764</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan J, Shan W, Yang H, Zhu F, Liu X, and Wang Q
2019. Neural activities in multiple rat brain regions in lithium-pilocarpine-induced status epilepticus model. Front Mol Neurosci. 12:323. doi: 10.3389/fnmol.2019.00323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2019.00323</ArticleId>
            <ArticleId IdType="pmc">PMC6974466</ArticleId>
            <ArticleId IdType="pubmed">32009899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang J, Wang Y, and Krueger JM
1998. Effects of interleukin-1 beta on sleep are mediatedby the type I receptor. Am J Physiol. 274:R655–660. doi: 10.1152/ajpregu.1998.274.3.R655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.1998.274.3.R655</ArticleId>
            <ArticleId IdType="pubmed">9530230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fogal B, and Hewett SJ
2008. Interleukin-1beta: a bridge between inflammation and excitotoxicity? J Neurochem. 106:1–23. doi: 10.1111/j.1471-4159.2008.05315.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2008.05315.x</ArticleId>
            <ArticleId IdType="pubmed">18315560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frank MG, Baratta MV, Zhang K, Fallon IP, Pearson MA, Liu G, Hutchinson MR, Watkins LR, Goldys EM, and Maier SF
2020. Acute stress induces the rapid and transient induction of caspase-1, gasdermin D and release of constitutive IL-1beta protein in dorsal hippocampus. Brain Behav Immun. 90:70–80. doi: 10.1016/j.bbi.2020.07.042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2020.07.042</ArticleId>
            <ArticleId IdType="pmc">PMC7544655</ArticleId>
            <ArticleId IdType="pubmed">32750541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman WJ
2001. Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp Neurol. 168:23–31. doi: 10.1006/exnr.2000.7595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/exnr.2000.7595</ArticleId>
            <ArticleId IdType="pubmed">11170718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gardoni F, Boraso M, Zianni E, Corsini E, Galli CL, Cattabeni F, Marinovich M, Di Luca M, and Viviani B
2011. Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1beta and NMDA stimulation. J Neuroinflammation. 8:14. doi: 10.1186/1742-2094-8-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-8-14</ArticleId>
            <ArticleId IdType="pmc">PMC3045339</ArticleId>
            <ArticleId IdType="pubmed">21314939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, and Morrissey PJ
1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol. 159:3364–3371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9317135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong Y, and Hewett JA
2018. Maintenance of the innate seizure threshold by cyclooxygenase-2 is not influenced by the translational silencer, T-cell intracellular antigen-1. Neuroscience. 373:37–51. doi: 10.1016/j.neuroscience.2018.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2018.01.004</ArticleId>
            <ArticleId IdType="pmc">PMC5816693</ArticleId>
            <ArticleId IdType="pubmed">29337236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goshen I, Kreisel T, Ounallah-Saad H, Renbaum P, Zalzstein Y, Ben-Hur T, Levy-Lahad E, and Yirmiya R
2007. A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology. 32:1106–1115. doi: 10.1016/j.psyneuen.2007.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2007.09.004</ArticleId>
            <ArticleId IdType="pubmed">17976923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haider B, Duque A, Hasenstaub AR, and McCormick DA
2006. Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition. J Neurosci. 26:4535–4545; doi: 10.1523/JNEUROSCI.5297-05.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5297-05.2006</ArticleId>
            <ArticleId IdType="pmc">PMC6674060</ArticleId>
            <ArticleId IdType="pubmed">16641233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen MK, Taishi P, Chen Z, and Krueger JM
1998. Vagotomy blocks the induction of interleukin-1beta (IL-1beta) mRNA in the brain of rats in response to systemic IL-1beta. J Neurosci. 18:2247–2253. doi: 10.1523/JNEUROSCI.18-06-02247.1998.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.18-06-02247.1998</ArticleId>
            <ArticleId IdType="pmc">PMC6792909</ArticleId>
            <ArticleId IdType="pubmed">9482809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He Y, Hara H, and Núñez G. 2016. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 41:1012–1021. doi: 10.1016/j.tibs.2016.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2016.09.002</ArticleId>
            <ArticleId IdType="pmc">PMC5123939</ArticleId>
            <ArticleId IdType="pubmed">27669650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hewett JA, Hewett SJ, Winkler S, and Pfeiffer SE
1999. Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia. J Neurosci Res. 56:189–198. Erratum in: J Neurosci Res 1999 Aug 1;57(3):411. doi: 10.1002/(sici)1097-4547(19990415)56:2&lt;189::aid-jnr8&gt;3.0.co;2-b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(sici)1097-4547(19990415)56:2&lt;189::aid-jnr8&gt;3.0.co;2-b</ArticleId>
            <ArticleId IdType="pubmed">10494107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hewett SJ, Jackman NA, and Claycomb RJ
2012. Interleukin-1beta in central nervous system injury and repair. Eur J Neurodegener Dis. 1:195–211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4465544</ArticleId>
            <ArticleId IdType="pubmed">26082912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hewett SJ, Shi J, Gong Y, Dhandapani K, Pilbeam C, and Hewett JA
2016. Spontaneous glutamatergic synaptic activity regulates constitutive COX-2 expression in neurons: Opposing roles for the transcription factors CREB (cAMP response element binding) protein and Sp1 (stimulatory protein-1). J Biol Chem. 291:27279–27288. doi: 10.1074/jbc.M116.737353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M116.737353</ArticleId>
            <ArticleId IdType="pmc">PMC5207154</ArticleId>
            <ArticleId IdType="pubmed">27875294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosoi T, Okuma Y, and Nomura Y
2000. Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. Am J Physiol RegulIntegr Comp Physiol. 279:R141–147. doi: 10.1152/ajpregu.2000.279.1.R141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.2000.279.1.R141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang RQ, Bell-Horner CL, Dibas MI, Covey DF, Drewe JA, and Dillon GH
2001. Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J Pharmacol Exp Ther. 298:986–995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11504794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaczmarek-Hajek K, Zhang J, Kopp R, Grosche A, Rissiek B, Saul A, Bruzzone S, Engel T, Jooss T, Krautloher A, Schuster S, Magnus T, Stadelmann C, Sirko S, Koch-Nolte F, Eulenburg V, and Nicke A
2018. Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody. Elife. 7:e36217. doi: 10.7554/eLife.36217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.36217</ArticleId>
            <ArticleId IdType="pmc">PMC6140716</ArticleId>
            <ArticleId IdType="pubmed">30074479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaushal V, Dye R, Pakavathkumar P, Foveau B, Flores J, Hyman B, Ghetti B, Koller BH, and LeBlanc AC
2015. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Cell Death Differ. 22:1676–1686. doi: 10.1038/cdd.2015.16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2015.16</ArticleId>
            <ArticleId IdType="pmc">PMC4563782</ArticleId>
            <ArticleId IdType="pubmed">25744023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krueger JM, Fang J, Taishi P, Chen Z, Kushikata T, and Gardi J
1998. Sleep. A physiologic role for IL-1 beta and TNF-alpha. Ann N Y Acad Sci. 856:148–159. doi: 10.1111/j.1749-6632.1998.tb08323.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1749-6632.1998.tb08323.x</ArticleId>
            <ArticleId IdType="pubmed">9917875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laye S, Bluthe RM, Kent S, Combe C, Medina C, Parnet P, Kelley K, and Dantzer R
1995. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol. 268:R1327–1331. doi: 10.1152/ajpregu.1995.268.5.R1327.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.1995.268.5.R1327</ArticleId>
            <ArticleId IdType="pubmed">7771597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lein E, Hawrylycz M, Ao N
et al.
2007. Genome-wide atlas of gene expression in the adult mousebrain. Nature
445:168–176. doi: 10.1038/nature05453.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature05453</ArticleId>
            <ArticleId IdType="pubmed">17151600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, and Reichlin S
1990. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 514:135–140. doi: 10.1016/0006-8993(90)90445-h.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(90)90445-h</ArticleId>
            <ArticleId IdType="pubmed">2357520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Nemeth DP, McKim DB, Zhu L, DiSabato DJ, Berdysz O, Gorantla G, Oliver B, Witcher KG, Wang Y, Negray CE, Vegesna RS, Sheridan JF, Godbout JP, Robson MJ, Blakely RD, Popovich PG, Bilbo SD, and Quan N
2019. Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities. Immunity. 50:764–766. Erratum in: Immunity. 2019 Mar 19;50(3):764–766. doi: 10.1016/j.immuni.2018.12.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2018.12.012</ArticleId>
            <ArticleId IdType="pubmed">30893590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Yamashita T, Chen Q, Belevych N, McKim DB, Tarr AJ, Coppola V, Nath N, Nemeth DP, Syed ZW, Sheridan JF, Godbout JP, Zuo J, and Quan N
2015. Interleukin 1 type 1 receptor restore: a genetic mouse model for studying interleukin 1 receptor- mediated effects in specific cell types. J Neurosci. 35:2860–2870. doi: 10.1523/JNEUROSCI.3199-14.2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3199-14.2015</ArticleId>
            <ArticleId IdType="pmc">PMC4331620</ArticleId>
            <ArticleId IdType="pubmed">25698726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, and Schmittgen TD
2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. doi: 10.1006/meth.2001.1262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma M, Huang J, Wang Y, Eipper BA, and Mains RE
2003. Kalirin, a multifunctional Rho guanine nucleotide exchange factor, is necessary for maintenance of hippocampalpyramidal neuron dendrites and dendritic spines. J Neurosci. 23:10593–10603. doi: 10.1523/JNEUROSCI.23-33-10593.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.23-33-10593.2003</ArticleId>
            <ArticleId IdType="pmc">PMC6740925</ArticleId>
            <ArticleId IdType="pubmed">14627644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCloy RA, Rogers S, Caldon CE, Lorca T, Castro A, and Burgess A
2014. Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. CellCycle. 13:1400–1412. doi: 10.4161/cc.28401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cc.28401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metzger MW, Walser SM, Aprile-Garcia F, Dedic N, Chen A, Holsboer F, Arzt E, Wurst W, and Deussing JM
2017. Genetically dissecting P2rx7 expression within the central nervous system using conditional humanized mice. Purinergic Signal. 13:153–170. doi: 10.1007/s11302-016-9546-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11302-016-9546-z</ArticleId>
            <ArticleId IdType="pmc">PMC5432476</ArticleId>
            <ArticleId IdType="pubmed">27858314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgan JI, Cohen DR, Hempstead JL, and Curran T
1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science. 237:192–197. doi: 10.1126/science.3037702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.3037702</ArticleId>
            <ArticleId IdType="pubmed">3037702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Opp MR, Obal F Jr., and Krueger JM
1991. Interleukin 1 alters rat sleep: temporal anddose-related effects. Am J Physiol. 260:R52–58. doi: 10.1152/ajpregu.1991.260.1.R52.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpregu.1991.260.1.R52</ArticleId>
            <ArticleId IdType="pubmed">1992828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phelps CP, Sahu A, Oliver J, Ma X-L, Kalra PS, Kalra SP, Menzies RA, Chen L, Denker M, Horvath E Poole L.L. 1995. In vivo release of interleukin-1 beta into hypothalamic extracellular fluid in rats: effects of repeated sampling. Brain Res. 688:193–197. doi: 10.1016/0006-8993(95)00491-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-8993(95)00491-8</ArticleId>
            <ArticleId IdType="pubmed">8542307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, and Rubartelli A
2008. ATP is releasedby monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A. 105:8067–8072. doi: 10.1073/pnas.0709684105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0709684105</ArticleId>
            <ArticleId IdType="pmc">PMC2430360</ArticleId>
            <ArticleId IdType="pubmed">18523012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piccioli P, and Rubartelli A
2013. The secretion of IL-1beta and options for release. Semin Immunol. 25:425–429. doi: 10.1016/j.smim.2013.10.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smim.2013.10.007</ArticleId>
            <ArticleId IdType="pubmed">24201029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinteaux E, Trotter P, and Simi A
2009. Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine. 45:1–7. doi: 10.1016/j.cyto.2008.10.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cyto.2008.10.008</ArticleId>
            <ArticleId IdType="pubmed">19026559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quan N, Zhang Z, Emery M, Bonsall R, and Weiss JM
1996. Detection of interleukin-1 bioactivity in various brain regions of normal healthy rats. Neuroimmunomodulation.3:47–55.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8892360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramanjaneyulu R, and Ticku MK
1984. Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur J Pharmacol. 98:337–345. doi: 10.1016/0014-2999(84)90282-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2999(84)90282-6</ArticleId>
            <ArticleId IdType="pubmed">6327331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross FM, Allan SM, Rothwell NJ, and Verkhratsky A
2003. A dual role for interleukin-1in LTP in mouse hippocampal slices. J Neuroimmunol. 144:61–67. doi: 10.1016/0014-2999(84)90282-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0014-2999(84)90282-6</ArticleId>
            <ArticleId IdType="pubmed">14597099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothwell NJ, and Luheshi GN
2000. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23:618–625. doi: 10.1016/s0166-2236(00)01661-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0166-2236(00)01661-1</ArticleId>
            <ArticleId IdType="pubmed">11137152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubartelli A, Cozzolino F, Talio M, and Sitia R
1990. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9:1503–1510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC551842</ArticleId>
            <ArticleId IdType="pubmed">2328723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, and Besedovsky HO
1998. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A. 95:7778–7783. doi: 10.1073/pnas.95.13.7778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.95.13.7778</ArticleId>
            <ArticleId IdType="pmc">PMC22755</ArticleId>
            <ArticleId IdType="pubmed">9636227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaftel SS, Griffin WS, and O’Banion MK
2008. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation
5:7. doi: 10.1186/1742-2094-5-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-5-7</ArticleId>
            <ArticleId IdType="pmc">PMC2335091</ArticleId>
            <ArticleId IdType="pubmed">18302763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simi A, Tsakiri N, Wang P and Rothwell NJ
2007. Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans. 35:1122–1126. doi: 10.1042/BST0351122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BST0351122</ArticleId>
            <ArticleId IdType="pubmed">17956293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohal VS and Rubenstein JLR
Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders. Mol Psychiatry
24, 1248–1257 (2019). doi: 10.1038/s41380-019-0426-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41380-019-0426-0</ArticleId>
            <ArticleId IdType="pmc">PMC6742424</ArticleId>
            <ArticleId IdType="pubmed">31089192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sperlagh B, and Illes P
2014. P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci. 35:537–547. doi: 10.1016/j.tips.2014.08.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tips.2014.08.002</ArticleId>
            <ArticleId IdType="pubmed">25223574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sperlagh B, Kofalvi A, Deuchars J, Atkinson L, Milligan CJ, Buckley NJ, and Vizi ES
2002. Involvement of P2X7 receptors in the regulation of neurotransmitter release in therat hippocampus. J Neurochem. 81:1196–1211. doi: 10.1046/j.1471-4159.2002.00920.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1471-4159.2002.00920.x</ArticleId>
            <ArticleId IdType="pubmed">12068068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stylianou E, O’Neill LA, Rawlinson L, Edbrooke MR, Woo P, and Saklatvala J
1992. Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. J Biol Chem. 267:15836–15841.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1386364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Summy-Long JY, Hu S, Long A, and Phillips TM
2008. Interleukin-1beta release in the supraoptic nucleus area during osmotic stimulation requires neural function. J Neuroendocrinol. 20:1224–1232. doi: 10.1111/j.1365-2826.2008.01783.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2826.2008.01783.x</ArticleId>
            <ArticleId IdType="pmc">PMC2585151</ArticleId>
            <ArticleId IdType="pubmed">18752652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Summy-Long JY, Hu S, Pruss A, Chen X, and Phillips TM
2006. Response of interleukin-1beta in the magnocellular system to salt-loading. J Neuroendocrinol. 18:926–937. doi: 10.1111/j.1365-2826.2006.01490.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2826.2006.01490.x</ArticleId>
            <ArticleId IdType="pubmed">17076768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swanson KV, Deng M, and Ting JP
2019. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 19:477–489. doi: 10.1038/s41577-019-0165-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41577-019-0165-0</ArticleId>
            <ArticleId IdType="pmc">PMC7807242</ArticleId>
            <ArticleId IdType="pubmed">31036962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taishi P, Bredow S, Guha-Thakurta N, Obal F Jr., and Krueger JM
1997. Diurnal variation of interleukin-1 beta mRNA and beta-actin mRNA in rat brain. J Neuroimmunol. 75:69–74. doi: 10.1016/s0165-5728(97)00002-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0165-5728(97)00002-7</ArticleId>
            <ArticleId IdType="pubmed">9143239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takemiya T, Fumizawa K, Yamagata K, Iwakura Y, and Kawakami M
2017. Brain interleukin-1 facilitates learning of a water maze spatial memory task in young mice. Front Behav Neurosci. 11:202. doi: 10.3389/fnbeh.2017.00202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnbeh.2017.00202</ArticleId>
            <ArticleId IdType="pmc">PMC5662897</ArticleId>
            <ArticleId IdType="pubmed">29123474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tringali G, Mancuso C, Mirtella A, Pozzoli G, Parente L, Preziosi P, and Navarra P
1996. Evidence for the neuronal origin of immunoreactive interleukin-1 beta released by rat hypothalamic explants. Neurosci Lett. 219:143–146. doi: 10.1016/s0304-3940(96)13195-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0304-3940(96)13195-5</ArticleId>
            <ArticleId IdType="pubmed">8971800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uliasz TF, Hamby ME, Jackman NA, Hewett JA, and Hewett SJ
2012. Generation of primary astrocyte cultures devoid of contaminating microglia. Methods Mol Biol. 814:61–79. doi: 10.1007/978-1-61779-452-0_5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-61779-452-0_5</ArticleId>
            <ArticleId IdType="pubmed">22144300</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, and Jacque C
2000. Cytokine signals propagate through the brain. Mol Psychiatry. 5:604–615. Erratum in: Mol Psychiatry 2001 Mar;6(2):249. doi: 10.1038/sj.mp.4000813.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4000813</ArticleId>
            <ArticleId IdType="pubmed">11126391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watt JA, and Hobbs NK
2000. Interleukin-1beta immunoreactivity in identified neurons of the rat magnocellular neurosecretory system: evidence for activity-dependent release. J Neurosci Res. 60:478–489. doi: 10.1002/(SICI)1097-4547(20000515)60:4&lt;478::AID-JNR6&gt;3.0.CO;2-R.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-4547(20000515)60:4&lt;478::AID-JNR6&gt;3.0.CO;2-R</ArticleId>
            <ArticleId IdType="pubmed">10797550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber A, Wasiliew P, and Kracht M
2010. Interleukin-1β (IL-1β) processing pathway. Sci Signal. 2010
Jan
19;3(105):cm2. doi: 10.1126/scisignal.3105cm2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.3105cm2</ArticleId>
            <ArticleId IdType="pubmed">20086236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wieczorek M, and Dunn AJ
2006. Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats. Brain Res. 1101:73–84. doi: 10.1016/j.brainres.2006.04.120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2006.04.120</ArticleId>
            <ArticleId IdType="pmc">PMC1976279</ArticleId>
            <ArticleId IdType="pubmed">16784727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yabuuchi K, Minami M, Katsumata S, and Satoh M
1994. Localization of type I interleukin-1 receptor mRNA in the rat brain. Brain Res Mol Brain Res. 27:27–36. doi: 10.1016/0169-328x(94)90180-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0169-328x(94)90180-5</ArticleId>
            <ArticleId IdType="pubmed">7877451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, and Worley PF
1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:371–386. doi: 10.1016/0896-6273(93)90192-t.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0896-6273(93)90192-t</ArticleId>
            <ArticleId IdType="pubmed">8352945</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
